(Reuters) - U.S. military veterans face racial and ethnic inequities in access to Novo Nordisk's highly in-demand drugs for ...

The "Today" host underwent gastric bypass surgery in 2002 to help him lose weight.

Weight loss can be a challenge, even for those who eat healthily and exercise regularly. But injectable type 2 diabetes ...

FAT jabs such as Ozempic and Wegovy could be “game changers” in tackling bowel cancer within five years, researchers have claimed Evidence has already shown that injections of the weight-loss drugs ...

In what could be a revolutionary stride in cancer care, scientists are exploring metabolism-targeting injections as a ...

Drugs that belong to the class of GLP-1 receptor agonists could cause muscle loss These drugs reduce appetite ... These drugs ...

When it comes to weight loss, finding the right solution can feel like searching for a needle in a haystack. For many, Ozempic has emerged as a standout ...

This will also explore the effect that jabs like weight-loss product Wegovy or the type 2 diabetes treatment Ozempic could ...

Fact checked by Nick Blackmer A recent study found that semaglutide, a GLP-1 weight loss drug, reduced knee pain in people with obesity and knee osteoarthritis.Experts say the reduced knee pain ...

In recent health news, Chinese scientists stress the need for regional diets to combat obesity, U.S. minority veterans ...

Novo Nordisk's stock has dropped to $110 per share, but operational performance remains strong. See why I believe we are at ...

In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...